ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

QNTA Quanta Inc (CE)

0.0001
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Day High

Low
0.0001

52 Week Range

High
0.0002

Day Low
Company Name Stock Ticker Symbol Market Type
Quanta Inc (CE) QNTA OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0001 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0001 0.0001
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0001 - 0.0002
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0001 USD

Quanta Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 50.56k 505.63M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Quanta (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QNTA Message Board. Create One! See More Posts on QNTA Message Board See More Message Board Posts

Historical QNTA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.00020.00020.00010.0001988175,790-0.0001-50.00%
3 Years0.049750.220.00010.04426873,346,153-0.04965-99.80%
5 Years2.0619.000.00010.04751671,855,236-2.06-100.00%

Quanta (CE) Description

Quanta Inc., an applied science company, focuses on enhancing energy levels in plant matter to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company specializes in potentiating rare, naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Through its subsidiary, Medolife Rx, Inc., the company's lead clinical development program includes Escozine, a proprietary formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company's polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. Medolife Rx has also launched the Immunapen line of immune system enhancers, which meet the needs of people that want to stay healthy, while providing additional benefits such as reduction in anxiety or stress, as well as increased energy and focus.

Your Recent History

Delayed Upgrade Clock